vericel
report
financial
results
november
cambridge
globe
newswire
vericel
corporation
nasdaq
vcel
leader
advanced
therapies
sports
medicine
severe
burn
care
markets
today
announced
following
webcast
conference
call
discuss
financial
results
business
highlights
vericel
corporation
earnings
call
thursday
november
edt
http
conference
call
available
live
investors
section
vericel
website
http
please
access
site
least
minutes
prior
scheduled
start
time
order
download
required
audio
software
necessary
presentation
slides
conference
call
available
webcast
investor
relations
section
vericel
website
participate
live
call
telephone
please
call
reference
vericel
corporation
earnings
call
calling
outside
please
use
international
phone
number
unable
participate
live
call
webcast
available
http
november
replay
call
also
available
edt
november
calling
outside
conference
id
vericel
corporation
vericel
leader
advanced
therapies
sports
medicine
severe
burn
care
markets
company
markets
two
cell
therapy
products
united
states
autologous
cultured
chondrocytes
porcine
collagen
membrane
autologous
cellularized
scaffold
product
indicated
repair
symptomatic
single
multiple
cartilage
defects
knee
without
bone
involvement
adults
cultured
epidermal
autografts
permanent
skin
replacement
treatment
patients
deep
dermal
full
thickness
burns
greater
equal
total
body
surface
area
company
also
holds
exclusive
license
north
american
commercial
rights
biological
orphan
product
debridement
severe
thermal
burns
information
please
visit
company
website
registered
trademarks
vericel
corporation
registered
trademark
mediwound
used
license
vericel
corporation
vericel
corporation
rights
reserved
investor
contact
lee
stern
solebury
trout
lstern
